Stay updated on Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.

Latest updates to the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page
- Check3 days agoChange DetectedThe page now shows revision v3.6.6, replacing v3.6.5. This indicates a system or template update rather than a substantive change to the study details.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page's revision indicator was updated to Revision: v3.6.5. Several legacy sponsor, collaborator, and study document references were removed, resulting in a leaner Study Details page while preserving essential trial information.SummaryDifference20%

- Check38 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a minor update to the page's metadata. This reflects an update to the page's revision history rather than study content.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a minor update to the study record (likely QC or formatting adjustments) without substantive changes to the study details.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page gains new study metadata and documentation, including sponsor and investigators, collaborators, and links to the Study Protocol and SAP, as well as IPD sharing information and related MeSH terms.SummaryDifference73%

- Check74 days agoChange DetectedNo additions or deletions were provided in the data, so there is no change to evaluate. The study details content remains as documented on the page.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.